Global Orthopedic Hyaluronic Acid Market Insights, Research, Forecast to 2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 113

Report ID: 348207

hyaluronic acid is a glycosaminoglycan found in synovial fluid & cartilage
The global Orthopedic Hyaluronic Acid market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orthopedic Hyaluronic Acid market based on company, product type, end user and key regions.

This report studies the global market size of Orthopedic Hyaluronic Acid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Orthopedic Hyaluronic Acid in these regions.
This research report categorizes the global Orthopedic Hyaluronic Acid market by top players/brands, region, type and end user. This report also studies the global Orthopedic Hyaluronic Acid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Anika Therapeutics
Seikagaku Corporation
Galderma
Sanofi (Genzyme)
Salix Pharmaceuticals
Allergan
Roche
Zimmer
Ferring Pharmaceuticals
Smith & Nephew

Market size by Product
Single Injection
Three Injection
Five Injection
Market size by End User
Hospitals
Ambulatory Surgical Centres
Orthopaedic Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Orthopedic Hyaluronic Acid market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Orthopedic Hyaluronic Acid market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Orthopedic Hyaluronic Acid companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Orthopedic Hyaluronic Acid submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Orthopedic Hyaluronic Acid are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orthopedic Hyaluronic Acid market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Orthopedic Hyaluronic Acid Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Orthopedic Hyaluronic Acid Market Size Growth Rate by Product
1.4.2 Single Injection
1.4.3 Three Injection
1.4.4 Five Injection
1.5 Market by End User
1.5.1 Global Orthopedic Hyaluronic Acid Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centres
1.5.4 Orthopaedic Clinics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Orthopedic Hyaluronic Acid Market Size
2.1.1 Global Orthopedic Hyaluronic Acid Revenue 2014-2025
2.1.2 Global Orthopedic Hyaluronic Acid Sales 2014-2025
2.2 Orthopedic Hyaluronic Acid Growth Rate by Regions
2.2.1 Global Orthopedic Hyaluronic Acid Sales by Regions
2.2.2 Global Orthopedic Hyaluronic Acid Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Orthopedic Hyaluronic Acid Sales by Manufacturers
3.1.1 Orthopedic Hyaluronic Acid Sales by Manufacturers
3.1.2 Orthopedic Hyaluronic Acid Sales Market Share by Manufacturers
3.1.3 Global Orthopedic Hyaluronic Acid Market Concentration Ratio (CR5 and HHI)
3.2 Orthopedic Hyaluronic Acid Revenue by Manufacturers
3.2.1 Orthopedic Hyaluronic Acid Revenue by Manufacturers (2014-2019)
3.2.2 Orthopedic Hyaluronic Acid Revenue Share by Manufacturers (2014-2019)
3.3 Orthopedic Hyaluronic Acid Price by Manufacturers
3.4 Orthopedic Hyaluronic Acid Manufacturing Base Distribution, Product Types
3.4.1 Orthopedic Hyaluronic Acid Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orthopedic Hyaluronic Acid Product Type
3.4.3 Date of International Manufacturers Enter into Orthopedic Hyaluronic Acid Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Orthopedic Hyaluronic Acid Sales by Product
4.2 Global Orthopedic Hyaluronic Acid Revenue by Product
4.3 Orthopedic Hyaluronic Acid Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Orthopedic Hyaluronic Acid Breakdown Data by End User

6 North America
6.1 North America Orthopedic Hyaluronic Acid by Countries
6.1.1 North America Orthopedic Hyaluronic Acid Sales by Countries
6.1.2 North America Orthopedic Hyaluronic Acid Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Orthopedic Hyaluronic Acid by Product
6.3 North America Orthopedic Hyaluronic Acid by End User

7 Europe
7.1 Europe Orthopedic Hyaluronic Acid by Countries
7.1.1 Europe Orthopedic Hyaluronic Acid Sales by Countries
7.1.2 Europe Orthopedic Hyaluronic Acid Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orthopedic Hyaluronic Acid by Product
7.3 Europe Orthopedic Hyaluronic Acid by End User

8 Asia Pacific
8.1 Asia Pacific Orthopedic Hyaluronic Acid by Countries
8.1.1 Asia Pacific Orthopedic Hyaluronic Acid Sales by Countries
8.1.2 Asia Pacific Orthopedic Hyaluronic Acid Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Orthopedic Hyaluronic Acid by Product
8.3 Asia Pacific Orthopedic Hyaluronic Acid by End User

9 Central & South America
9.1 Central & South America Orthopedic Hyaluronic Acid by Countries
9.1.1 Central & South America Orthopedic Hyaluronic Acid Sales by Countries
9.1.2 Central & South America Orthopedic Hyaluronic Acid Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Orthopedic Hyaluronic Acid by Product
9.3 Central & South America Orthopedic Hyaluronic Acid by End User

10 Middle East and Africa
10.1 Middle East and Africa Orthopedic Hyaluronic Acid by Countries
10.1.1 Middle East and Africa Orthopedic Hyaluronic Acid Sales by Countries
10.1.2 Middle East and Africa Orthopedic Hyaluronic Acid Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Orthopedic Hyaluronic Acid by Product
10.3 Middle East and Africa Orthopedic Hyaluronic Acid by End User

11 Company Profiles
11.1 Anika Therapeutics
11.1.1 Anika Therapeutics Company Details
11.1.2 Company Business Overview
11.1.3 Anika Therapeutics Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Anika Therapeutics Orthopedic Hyaluronic Acid Products Offered
11.1.5 Anika Therapeutics Recent Development
11.2 Seikagaku Corporation
11.2.1 Seikagaku Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Seikagaku Corporation Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Seikagaku Corporation Orthopedic Hyaluronic Acid Products Offered
11.2.5 Seikagaku Corporation Recent Development
11.3 Galderma
11.3.1 Galderma Company Details
11.3.2 Company Business Overview
11.3.3 Galderma Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Galderma Orthopedic Hyaluronic Acid Products Offered
11.3.5 Galderma Recent Development
11.4 Sanofi (Genzyme)
11.4.1 Sanofi (Genzyme) Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi (Genzyme) Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi (Genzyme) Orthopedic Hyaluronic Acid Products Offered
11.4.5 Sanofi (Genzyme) Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Salix Pharmaceuticals Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Salix Pharmaceuticals Orthopedic Hyaluronic Acid Products Offered
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Business Overview
11.6.3 Allergan Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Allergan Orthopedic Hyaluronic Acid Products Offered
11.6.5 Allergan Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Company Business Overview
11.7.3 Roche Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Roche Orthopedic Hyaluronic Acid Products Offered
11.7.5 Roche Recent Development
11.8 Zimmer
11.8.1 Zimmer Company Details
11.8.2 Company Business Overview
11.8.3 Zimmer Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Zimmer Orthopedic Hyaluronic Acid Products Offered
11.8.5 Zimmer Recent Development
11.9 Ferring Pharmaceuticals
11.9.1 Ferring Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Ferring Pharmaceuticals Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ferring Pharmaceuticals Orthopedic Hyaluronic Acid Products Offered
11.9.5 Ferring Pharmaceuticals Recent Development
11.10 Smith & Nephew
11.10.1 Smith & Nephew Company Details
11.10.2 Company Business Overview
11.10.3 Smith & Nephew Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Smith & Nephew Orthopedic Hyaluronic Acid Products Offered
11.10.5 Smith & Nephew Recent Development

12 Future Forecast
12.1 Orthopedic Hyaluronic Acid Market Forecast by Regions
12.1.1 Global Orthopedic Hyaluronic Acid Sales Forecast by Regions 2019-2025
12.1.2 Global Orthopedic Hyaluronic Acid Revenue Forecast by Regions 2019-2025
12.2 Orthopedic Hyaluronic Acid Market Forecast by Product
12.2.1 Global Orthopedic Hyaluronic Acid Sales Forecast by Product 2019-2025
12.2.2 Global Orthopedic Hyaluronic Acid Revenue Forecast by Product 2019-2025
12.3 Orthopedic Hyaluronic Acid Market Forecast by End User
12.4 North America Orthopedic Hyaluronic Acid Forecast
12.5 Europe Orthopedic Hyaluronic Acid Forecast
12.6 Asia Pacific Orthopedic Hyaluronic Acid Forecast
12.7 Central & South America Orthopedic Hyaluronic Acid Forecast
12.8 Middle East and Africa Orthopedic Hyaluronic Acid Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orthopedic Hyaluronic Acid Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer